Familial drusen, encompassing conditions like Doyne Honeycomb Retinal Dystrophy and Malattia Leventinese, is fundamentally a genetic disorder. Understanding its genetic basis is crucial for patients and their families, particularly when it comes to family planning and assessing the risk for future generations.
The condition is primarily caused by a specific mutation in the EFEMP1 gene, located on chromosome 2. This gene provides instructions for making a protein that is part of the extracellular matrix, a network that provides structural support to cells. The mutation leads to the abnormal accumulation of this protein and other substances beneath the retina, forming the characteristic drusen deposits.
Familial drusen follows an autosomal dominant pattern of inheritance. This means that an individual only needs to inherit one copy of the mutated gene from either parent to develop the condition. Consequently, if one parent has familial drusen, each of their children has a 50% chance of inheriting the mutated gene and the disorder. It affects both males and females equally.
Because of this inheritance pattern, genetic testing and counseling are highly recommended for affected individuals and their families. A genetic counselor can help interpret test results, explain the risks to family members, and discuss options for family planning. Identifying the specific mutation can also be important for confirming the diagnosis and determining eligibility for future gene-specific clinical trials.
While the genetic nature of familial drusen means it can be passed down through generations, knowledge is power. By understanding the genetics of the condition, families can make informed decisions and work with their healthcare providers to monitor and manage their eye health proactively.